The rHEALTH Sensor was recently featured in the NASA Spinoff 2013 magazine.  This magazine features NASA-funded technologies that will be or are being commercialized in the near term.  In particular, it serves to highlight what NASA Administrator Charles Bolden calls “down-to-Earth benefits from space.”

The rHEALTH technology is designed to shrink an entire hospital testing laboratory onto a handheld device. A physician or healthcare provider performs the test by collecting a fingerstick of blood from a patient.

Our technology is not only designed for real-world use — it is engineered for the extreme. From deep-space missions to frontline medical care, DNS innovations have earned the trust of leading federal agencies through demonstrated performance, reliability, and breakthrough utility.

Eugene Chan, founder and CSO of DMI, tested a prototype of the rHEALTH sensor on zero- and lunar-gravity flights as part of the 2010 Facilitated Access to the Space Environment for Technology.

DNA Medicine Institute is highlighted in The Innovator’s Path, a groundbreaking book that explores how organizations can build — and sustain — a culture of innovation. Featuring commentary from Dr. Eugene Chan, the book offers practical strategies for transforming bold ideas into lasting impact.

DNA Medicine Institute continues its mission to transform patient care by bringing advanced hospital-grade diagnostics directly to the point of care. Through support from the U.S. government’s Qualifying Therapeutic Discovery Grant program, DMI is accelerating the development of its Universal Blood Sensor — a breakthrough technology that democratizes access to vital health information anywhere, anytime.

DNA Medicine Institute continues to break the boundaries of diagnostics by validating life-saving technology in one of the most unforgiving environments imaginable — microgravity. Through NASA’s FAST program, our rHEALTH® sensor has demonstrated its ability to operate as a universal blood diagnostic platform not only on Earth, but in space, where reliability is mission critical.

At DNA Medicine Institute, we are engineering the future of medical diagnostics — from bedside care on Earth to next-generation health monitoring in orbit. Our breakthrough rHEALTH® platform continues to earn national recognition and support from NASA for its potential to deliver hospital-grade testing in the most extreme environments. Below is an update on our latest milestone in partnership with NASA’s SBIR Program.

At DNA Medicine Institute, we are pioneering the future of autonomous healthcare — from deep space missions to austere and extreme environments on Earth. Our work focuses on transforming laboratory-scale diagnostics into compact, nanoscale systems capable of delivering full-spectrum health insights from just a single drop of blood. This technology equips astronauts — and eventually patients worldwide — with fast, reliable, and actionable medical data when traditional medical infrastructure is out of reach.

At DNA Medicine Institute, we are committed to transforming complex hospital diagnostics into fast, portable, and patient-ready tools that can be deployed anywhere — from modern medical centers to the most remote field locations. Our research is dedicated to empowering clinicians with life-saving insights in real time, without the barriers of large equipment or sophisticated lab infrastructure.

At DNA Medicine Institute, we are committed to transforming global health with technologies that are faster, smarter, and accessible to all. Our research pushes beyond conventional limits to create powerful medical tools that can be deployed anywhere in the world — even in the most resource-limited environments.